Background-The short chain fatty acid (SCFA) butyrate provides energy
for colonocytes, stimulates colonic fluid and electrolyte absorption a
nd is recognised as an effective treatment for multiple types of colit
is. Aim-To examine the impact of butyrate enema therapy on the clinica
l course, severity of inflammation, and SCFA stimulated Na+ absorption
in a chronic experimental colitis. Methods-Distal colitis was induced
in rats with a trinitrobenzenesulphonic acid (TNBS) enema. Five days
after induction, rats were divided into groups to receive: no treatmen
t, saline enemas, or 100 mM Na-butyrate enemas daily. On day 24, colon
ic damage score and tissue myeloperoxidase (MPO) activity were evaluat
ed. Colon was mounted in Ussing chambers and Na+ transport and electri
cal activities were measured during a basal period and after stimulati
on with 25 mM butyrate. Results-In the untreated and the saline enema
treated TNBS groups, diarrhoea and extensive colonic damage were seen,
associated with increased tissue MPO activities and absent butyrate s
timulated Na+ absorption. In contrast, in the butyrate enema treated T
NBS group, diarrhoea ceased, colonic damage score improved, and tissue
MPO activity as well as butyrate stimulated Na+ absorption recovered
to control values. Conclusion-Butyrate enema therapy stimulated coloni
c repair, as evidenced by clinical recovery, decreased inflammation, a
nd restoration of SCFA stimulated electrolyte absorption.